Join us at ESHG 2022 in Vienna for our Participants Workshop: The challenges of delivering NIPT
EMQN and GenQA are delighted to co-host a Non-Invasive Prenatal Testing workshop at ESHG 2022. It will be held on Sunday 12th June at 16:00-17:00 (CEST) in room 1.61-62.
Join us alongside our expert advisors as we present an overview of NIPT technologies, including their advantages and pitfalls, and discuss real case scenarios to highlight the challenges faced by clinical laboratories.
Registration is not required, however, seats will be allocated on a first come, first served basis.
Final Results of 2021 EQAs Published: NGS Somatic EQAs
Thank you to all who participated in our 2021 NGS Somatic EQA schemes.
The Final ILR, Scheme Summary Report and Certificate of Participation are now available for participants to view on our website. Please log in to your EMQN account to view these documents.
Membership Scheme Changes Starting in 2022
EMQN have recently undergone an organisational review, and as a result our membership scheme is evolving and adapting to fit in with both the needs of our members and our organisation. From 2022, we will be offering our membership at no yearly cost.
Click below to read EMQN’s full statement on our membership scheme changes as well as what’s new for 2022!
We are a not-for-profit organisation promoting quality in genomic testing by establishing, harmonising and disseminating best practice.
We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.
EQAs for SARS-Cov-2 and other respiratory viruses open for registration
We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.
The latest news and press releases
Final Results Published for 2021 Lung Cancer (NSCLC) [Plasma] EQA - https://t.co/JBD3eT3zQD
Enrol now for our free online assessment of BRCA1, BRCA2 and other HRR gene variants, 2022 variant classification (… https://t.co/mpnEUGpB5X
Press release: partnership with Novartis to expand EQA schemes to include a pilot program for MET exon 14 skipping - https://t.co/HFWnUWDWCg
You are invited! Live Webinar: Lessons learned from the 2021 EQA Scheme for BRCA and Other HRR Gene Variants in Ova… https://t.co/Msw2TN3a7d
Final Results Published for 2021 NIPT (Aneuploidies) and NIPT (Sexing) EQAs - https://t.co/GGcppVSZ1d